Anthropic revenue already exceeds two blockbuster drugs combined, X users note
ben_j_todd · x · 2026-10-13
In an X exchange, fleetingbits points out that Anthropic's revenue curve is already steeper than two blockbuster drugs combined, and benjtodd replies that the chart's x-axis simply "ends too early" — implying the gap keeps widening. A striking visualization of how AI revenue ramp speed outpaces the most successful products in history.
Related event: GLP-1 drugs earn about double OpenAI plus Anthropic revenue(3 posts)→
More from Venture
- AI search startup Exa hits $100M annualized revenue, growing ~10x a year for 3 years — TheIshanGoswami · 2026-10-14
- Latent Space cloned a $43K/yr SaaS with AI agents: 72 teams, $10K winner, lessons learned — Latent Space · 2026-10-14
- Nvidia takes stake in Doctolib as Jensen Huang pushes AI revolution in Europe — mitchdeg · 2026-10-14
- The Global AI Bust: What Will Survive When the Boom Ends — ForeignAffairsMag · 2026-10-14
- Lenny's Newsletter: what actually counts as a moat in the AI era — HamelHusain · 2026-10-14
- Zyfai launches MCP server to fund accounts via AI assistants — LexSokolin · 2026-10-14